List of insiders holdings for IDEAYA Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | CANAAN X L.P. Canaan Partners X LLC 10% Owner |
2024-02-01 16:33:27 | 1,570,820 0 |
1,570,820 | Form 13G |
| 2 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2024-11-14 16:23:02 | 1,409,993 0 |
1,409,993 | Form 13G |
| 3 | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner |
2021-08-11 16:31:32 | 1,398,066 0 |
1,398,066 | Form 13D |
| 4 | Hata Yujiro S President and CEO |
2025-02-28 18:00:28 | 600,000 0 |
600,000 | Form 4 |
| 5 | Alexandria Venture Investments LLC 10% Owner |
2019-05-30 18:12:17 | 432,384 0 |
432,384 | Form 4 |
| 6 | Beaupre Darrin Chief Medical Officer |
2025-02-28 18:03:47 | 185,000 0 |
185,000 | Form 4 |
| 7 | WHITE MICHAEL ANTHONY Chief Scientific Officer |
2025-02-28 18:01:16 | 185,000 0 |
185,000 | Form 4 |
| 8 | Hager Jeffrey SVP, Chief Technology Officer |
2019-07-30 19:20:15 | 138,249 0 |
138,249 | Form 4 |
| 9 | Throne Jason Chief Legal Officer |
2024-06-27 18:47:10 | 106,030 0 |
106,030 | Form 4 |
| 10 | Dillon Michael P. SVP, Chief Scientific Officer |
2021-10-07 16:11:25 | 102,226 0 |
102,226 | Form 4 |
| 11 | Ruiz Briseno Andres See Remarks |
2025-02-28 18:02:04 | 75,000 0 |
75,000 | Form 4 |
| 12 | Hambleton Julie SVP, Chief Medical Officer |
2020-02-25 16:02:06 | 62,500 0 |
62,500 | Form 4 |
| 13 | Lackner Mark SVP, Head of Biology |
2021-02-26 19:10:16 | 45,000 0 |
45,000 | Form 4 |
| 14 | Snyder Douglas B. SVP, General Counsel |
2025-02-28 18:00:54 | 33,000 0 |
33,000 | Form 4 |
| 15 | ROSEN TERRY J Director |
2024-05-31 16:38:35 | 16,200 0 |
16,200 | Form 4 |
| 16 | Kelley Susan L. Director |
2024-05-31 16:38:32 | 16,200 0 |
16,200 | Form 4 |
| 17 | Hampton Malcolm Garret Director |
2024-05-31 16:38:29 | 16,200 0 |
16,200 | Form 4 |
| 18 | Stein Jeffrey Director |
2024-05-31 16:38:25 | 16,200 0 |
16,200 | Form 4 |
| 19 | Morrison Scott W Director |
2024-05-31 16:38:19 | 16,200 0 |
16,200 | Form 4 |
| 20 | YARNO WENDY L Director |
2024-05-31 16:31:24 | 16,200 0 |
16,200 | Form 4 |
| 21 | MACKEY CATHERINE J Director |
2024-05-31 16:30:21 | 16,200 0 |
16,200 | Form 4 |
| 22 | SHANNON TIMOTHY M Director |
2023-06-09 16:49:22 | 16,200 0 |
16,200 | Form 4 |
| 23 | DORMAN STUART Chief Commercial Officer |
2025-02-28 18:02:27 | 15,000 0 |
15,000 | Form 4 |
| 24 | Stone Paul A. Chief Financial Officer |
2023-08-31 17:49:27 | 9,303 0 |
9,303 | Form 4 |
| 25 | Schroeder Thilo Director |
2019-05-22 21:19:52 | 0 0 |
0 | Form 3 |